This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Designing an IHC experiment for TRIP12? The guide has the expected staining pattern, antigen retrieval and fixation, antibodies backed by real IHC images, the tissue controls to run alongside, and protocols taken from published papers.
Open the TRIP12 IHC Guide
Facts about E3 ubiquitin-protein ligase TRIP12.
In normal cells, mediates ubiquitination and degradation of isoform p19ARF/ARF of CDKN2A, a lysine-less tumor suppressor needed for p53/TP53 activation under oncogenic stress. In cancer cells, however, isoform p19ARF/ARF and TRIP12 are located in different cell compartments, preventing isoform p19ARF/ARF ubiquitination and degradation.
| Human | |
|---|---|
| Gene Name: | TRIP12 |
| Uniprot: | Q14669 |
| Entrez: | 9320 |

| Belongs to: |
|---|
| UPL family |

EC 6.3.2.-; KIAA0045ULF; MGC138849; MGC138850; probable E3 ubiquitin-protein ligase TRIP12; thyroid hormone receptor interactor 12; thyroid receptor interacting protein 12; Thyroid receptor-interacting protein 12; TR-interacting protein 12; TRIP-12
Mass (kDA):
220.434 kDA

| Human | |
|---|---|
| Location: | 2q36.3 |
| Sequence: | 2; NC_000002.12 (229763837..229923234, complement) |
Nucleus, nucleoplasm.





PMID: 20208519 by Chen D., et al. Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses.
PMID: 7776974 by Lee J.W., et al. Two classes of proteins dependent on either the presence or absence of thyroid hormone for interaction with the thyroid hormone receptor.